Across TCGA pan-cancer cohorts, SMIM10L2B Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated SMIM10L2B data layer compared with 25 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher SMIM10L2B Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SMIM10L2B expression acts as an unfavorable survival marker.

UCEC are the cancer types where SMIM10L2B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: SMIM10L2B tumor-vs-normal RNA expression · all SMIM10L2B data types